Lehrstuhl für Haut- und Geschlechtskrankheiten

Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develop Autoimmunity After Influenza or LCMV Infections (2021) Szumilas N, Corneth OB, Lehmann C, Schmitt H, Cunz S, Cullen JG, Chu T, et al. Journal article β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression (2021) Hofbauer D, Mougiakakos D, Broggini L, Zaiss M, Büttner-Herold M, Bach C, Spriewald B, et al. Journal article Mechanical Regulation of Epithelial Tissue Homeostasis (2021) Kaliman S, Hubert M, Wollnik C, Nuic L, Vurnek D, Gehrer S, Lovrić J, et al. Journal article Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis. A Systematic Review (2021) Steeb T, Wessely A, Petzold A, Brinker TJ, Schmitz L, Leiter U, Garbe C, et al. Journal article, Review article Citrate-coated superparamagnetic iron oxide nanoparticles enable a stable non-spilling loading of t cells and their magnetic accumulation (2021) Boosz P, Pfister F, Stein R, Friedrich B, Fester L, Band J, Mühlberger M, et al. Journal article Maturation of monocyte-derived DCs leads to increased cellular stiffness, higher membrane fluidity, and changed lipid composition (2021) Lühr J, Alex N, Amon L, Kraeter M, Kubankova M, Sezgin E, Lehmann C, et al. Conference contribution S2k-Leitlinie zur Diagnostik und Therapie des kutanen Lupus erythematodes – Teil 1: Klassifikation, Diagnostik, Prävention und Aktivitätsscores (2021) Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Günther C, Iking-Konert C, et al. Journal article S2k guideline: Diagnosis and management of cutaneous lupus erythematosus - Part 1: Classification, diagnosis, prevention, activity scores (2021) Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Guenther C, Iking-Konert C, et al. Journal article Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis (2021) Koch E, Petzold A, Wessely A, Dippel E, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients (2021) Persa OD, Schatton K, Rübben A, Berking C, Erdmann M, Schlaak M, Mauch C, Steeb T Journal article